The mitochondrial enzyme 25-hydroxyvitamin D 3 -1␣-hydroxylase (1␣-hydroxylase) plays an important role in calcium homeostasis by catalyzing synthesis of the active form of vitamin D, 1,25-dihydroxyvitamin D 3 , in the kidney. However, enzyme activity assays indicate that 1␣-hydroxylase is also expressed in a variety of extrarenal tissues; recent cloning of cDNAs for 1␣-hydroxylase in different species suggests that a similar gene product is found at both renal and extrarenal sites. Using specific complementary ribonucleic acid probes and antisera to 1␣-hydroxylase, we have previously reported the distribution of messenger ribonucleic acid and protein for the enzyme along the mouse and human nephron. Here we describe further immunohistochemical and Western blot analyses that detail for the first time the extrarenal distribution of 1␣-hydroxylase in both normal and diseased tissues. Specific staining for 1␣-hydroxylase was detected in skin (basal keratinocytes, hair follicles), lymph nodes (granulomata), colon (epithelial cells and parasympathetic ganglia), pancreas (islets), adrenal medulla, brain (cerebellum and cerebral cortex), and placenta (decidual and trophoblastic cells). Further studies using psoriatic skin highlighted overexpression of 1␣-hydroxylase throughout the dysregulated stratum spinosum. Increased expression of skin 1␣-hydroxylase was also associated with sarcoidosis. In lymph nodes and skin from these patients 1␣-hydroxylase expression was observed in cells positive for the surface antigen CD68 (macrophages). The data presented here confirm the presence of protein for 1␣-hydroxylase in several extrarenal tissues, such as skin, placenta, and lymph nodes. The function of this enzyme at novel extrarenal sites, such as adrenal medulla, brain, pancreas, and colon, remains to be determined. However, the discrete patterns of staining in these tissues emphasizes a possible role for 1␣-hydroxylase as an intracrine modulator of vitamin D function in peripheral tissues. However, enzyme activity studies using a variety of tissues have suggested that synthesis of 1,25-(OH) 2 D 3 occurs at several key peripheral sites, including the immune system and skin (3, 8, 9) . In contrast to the kidney, which supports the systemic, endocrine actions of 1,25-(OH) 2 D 3 , extrarenal 1␣-hydroxylase appears to act in an autocrine or paracrine fashion by modulating cell differentiation and/or function at a local level (1-4, 10 -12). This has generated considerable interest in the possible application of 1,25-(OH) 2 D 3 and its analogs in the treatment of myeloid leukemias (10, 12), psoriasis, and type 1 diabetes (10, 11).
] is catalyzed by the mitochondrial cytochrome P450 enzyme, 25-hydroxyvitamin D 3 -1␣-hydroxylase (1␣-hydroxylase), which is classically expressed in the kidney (5-7). However, enzyme activity studies using a variety of tissues have suggested that synthesis of 1,25-(OH) 2 D 3 occurs at several key peripheral sites, including the immune system and skin (3, 8, 9) . In contrast to the kidney, which supports the systemic, endocrine actions of 1,25-(OH) 2 D 3 , extrarenal 1␣-hydroxylase appears to act in an autocrine or paracrine fashion by modulating cell differentiation and/or function at a local level (1-4, 10 -12) . This has generated considerable interest in the possible application of 1,25-(OH) 2 D 3 and its analogs in the treatment of myeloid leukemias (10, 12) , psoriasis, and type 1 diabetes (10, 11) .
The original description of extrarenal 1␣-hydroxylase was based on studies of the granulomatous disease sarcoidosis, which supported a link between ectopic synthesis of 1,25-(OH) 2 D 3 and the hypercalcemia that is frequently observed with this disorder (13) (14) (15) . Detailed analysis of lymph node homogenates and pulmonary alveolar macrophages from patients with sarcoidosis demonstrated significant levels of 25(OH)D 3 to 1,25-(OH) 2 D 3 conversion (16 -19) . Importantly, and in contrast to renal 1␣-hydroxylase, addition of exogenous 1,25-(OH) 2 D 3 did not inhibit macrophage 1␣-hydroxylase. This provided a potential mechanism for the apparently unregulated synthesis of 1,25-(OH) 2 D 3 that is characteristic of the more severe forms of this disease (14, 15) . It also suggested that the expression and regulation of 1␣-hydroxylase in extrarenal tissues were different from those observed with the kidney enzyme. Unfortunately, the absence of nucleotide and amino acid sequence data for 1␣-hydroxylase has, until recently, prevented further characterization of the extrarenal enzyme. However, in the last 2 yr several groups have reported gene and cDNA sequences for 1␣-hydroxylase in various species (20 -24) . As well as providing insight into the molecular basis of disorders associated with abnormal renal 1␣-hydroxylase expression (22, 23, (25) (26) (27) , these studies have generated new information on the ectopic expression of the enzyme. Most notably, the first normal and mutant human cDNAs for 1␣-hydroxylase were cloned from keratinocytes, an important extrarenal source of 1,25-(OH) 2 D 3 (11, 22, 28) . Studies indicate that a similar messenger ribonucleic acid (mRNA) for 1␣-hydroxylase is expressed in both renal and extrarenal tissues (22, 29) . Based on these observations we have used immunohistochemical techniques previously de-scribed for studies of the kidney (5) to characterize the tissue distribution of extrarenal 1␣-hydroxylase.
Materials and Methods

Tissue preparation
A tissue specimen database from University of Birmingham was screened for routine surgical samples that were classified as normal. Psoriatic skin and granulomata-forming diseases such as sarcoidosis and tuberculosis were also included. For each tissue five different paraffinembedded samples were used to produce tissue sections (5 m thick) on charged slides (SuperFrost Plus, BDH, Poole, UK).
Immunohistochemistry
Synthesis of a 1␣-hydroxylase antibody was carried out using an antigenic region of the reported mouse amino acid sequence, peptide 266 -289, as described previously (5, 30 ). An IgG fraction was subsequently prepared from the immune serum (The Binding Site, Birmingham, UK). Preliminary studies using a human proximal tubule cell line (HKC-8) that expresses 1␣-hydroxylase activity confirmed the specificity of the antiserum for a 56-kDa 1␣-hydroxylase protein (30) . Western blot analyses identified a single 1␣-hydroxylase protein species in these cells, and expression of this was down-regulated in the presence of 10 nmol/L 1,25-(OH) 2 D 3 and up-regulated by forskolin. Paraffin-embedded sections were processed in 0.01 mol/L sodium citrate buffer (pH 6.0) in a pressure cooker at 103 kPa for 2 min. Slides were incubated with methanol-hydrogen peroxide (1:100) to block endogenous peroxidase activity and then washed in Tris-buffered saline, pH 7.6. The slides were then incubated with 1␣-hydroxylase antiserum (1:150) in 10% normal swine serum for 45 min at 25 C. After rinsing with Tris-buffered saline for 15 min, donkey antisheep IgG peroxidase conjugate (1:100) was added to sections for 45 min. Staining was developed using 3,3Ј-diaminobenzidine (2.5 mg/ml) followed by counterstaining with Mayer's hematoxylin. Control sections included 1) omission of primary antibody, and 2) use of primary antibody preabsorbed with a 100-fold excess of immunizing peptide.
Western blot analysis
Further characterization of 1␣-hydroxylase protein expression was carried out by Western blot analysis using homogenates from selected tissues. As a positive control, lysates were also prepared from HKC-8 cells as described previously (30) . Tissue samples and cell preparations were washed in PBS containing 0.5 mmol/L phenylmethylsulfonylfluoride (Sigma, Poole, UK) and homogenized using a glass-Teflon homogenizer. Cell membranes were pelleted at 2,900 ϫ g at 4 C for 5 min, and the supernatant, containing the 1␣-hydroxylase protein, was stored at Ϫ80 C. Aliquots of protein were then subjected to SDS-PAGE (5.5 g/ lane) and electroblotted onto Immobilon P membrane as described previously (30) . Filters were blocked and incubated with primary antibody at a 1:500 dilution and with secondary antibody (horseradish peroxidase conjugated; Amersham Pharmacia Biotech, Aylesbury, UK) at a 1:75,000 dilution. Protein for 1␣-hydroxylase was detected by enhanced chemiluminescence (Amersham Pharmacia Biotech) after exposure of filters to x-ray film for 10 -30 s. Control experiments were included where 1) primary antibody was omitted; or 2) primary antibody was preabsorbed with a 100-fold excess of immunizing peptide. No protein bands were detected in these controls (data not shown).
Results
Initial studies shown in Fig. 1 were carried out to highlight the specificity of immunohistochemical methods for detec- tion of 1␣-hydroxylase. Figure 1A demonstrates the presence of 1␣-hydroxylase immunoreactivity in proximal convoluted tubules and more distal areas of the nephron (distal convoluted tubule/cortical collecting ducts and thick ascending loop of Henle). The specificity of this staining was confirmed by negative controls in which the antiserum was preabsorbed with a 100-fold excess of immunizing peptide (Fig.  1B) . The relatively high expression of 1␣-hydroxylase in the kidney was emphasized by parallel analysis of liver (Fig. 1C ) and heart tissue ( Fig. 1D) , which showed no staining for the enzyme.
Further studies were carried out using other extrarenal tissues that have previously been shown to have 1␣-hydroxylase activity (Fig. 2) . In normal skin, epidermal 1␣-hydroxylase expression was restricted to keratinocytes within the stratum basalis ( Fig. 2A) , although the enzyme was also expressed strongly in hair follicles (Fig. 2D) . As with kidney tissue, staining for 1␣-hydroxylase within the skin was completely eliminated by preincubation of antiserum with immunizing peptide (Fig. 2C) . In contrast to normal tissue, psoriatic skin samples showed widespread expression of 1␣-hydroxylase throughout the dysregulated stratum spinosum (Fig. 2B) . In normal lymph nodes, 1␣-hydroxylase was expressed in germinal centers (Fig. 2E) . Parallel staining for the cell surface antigen CD68 indicated that this corresponded to areas that were rich in macrophage populations (data not shown). Similar results were also obtained with sections of human tonsil tissue (Fig. 2F) . Parallel analyses using lymph tissue from patients with sarcoidosis showed strong expression of 1␣-hydroxylase, specifically in granulomata (Fig. 2G) . Interestingly, in skin from patients with sarcoidosis, 1␣-hydroxylase was readily detected in inflammatory infiltrates (CD68-positive cells), but was normally expressed in basal keratinocytes of the epidermis (Fig. 2H) .
The results shown in Fig. 3 indicate that 1␣-hydroxylase is expressed in a variety of other extrarenal tissues. Analysis of the colon showed positive staining in epithelial cells (Fig.  3A) , although 1␣-hydroxylase was also expressed strongly in parasympathetic ganglia of the myenteric plexus (Fig. 3B) . In the adrenal gland 1␣-hydroxylase was clearly localized to the medulla, with background staining observed in the cortex (Fig. 3D) . In the pancreas, 1␣-hydroxylase was clearly detectable in islet cells (Fig. 3C) , and expression of the enzyme was coincident with insulin secretion (data not shown). Strong immunoreactivity for 1␣-hydroxylase was observed in both decidualized stromal cells and cytrophoblastic cells of the placental bed (Fig. 3E) as well as the syncitiotrophoblastic cells (Fig. 3F) . The enzyme was also detectable in the brain, with strong expression in the Purkinje cells of the cerebellum (Fig. 3G) , and in the cerebral cortex (Fig. 3H) .
Western blot analyses were carried out to further characterize extrarenal 1␣-hydroxylase expression. The results in Fig. 4 show the presence of a 56-kDa protein species corresponding to the predicted size of 1␣-hydroxylase in renal (kidney cortex and medulla) and extrarenal (placenta) tissues. Tissues such as adrenal cortex, which showed no staining for 1␣-hydroxylase in immunohistochemical analyses, were negative in Western blots. The 1␣-hydroxylase antiserum also identified additional protein species in renal and extrarenal tissues. A larger band of approximately 65 kDa was less readily displaced by immunizing peptide than the 56-kDa species and was not observed in cultured HKC-8 cells (data not shown). A smaller species of approximately 40 kDa was detectable in placental tissue and could not be competed out with immunizing peptide.
Discussion
To date, analysis of the expression of 1␣-hydroxylase in renal and extrarenal tissues has relied upon enzyme activity studies using tissue homogenates or cultured cells, together with radiolabeled 25(OH)D 3 as substrate. In recent studies we have addressed this by developing complementary RNA probes and polyclonal antisera that have been used to characterize the tissue distribution of 1␣-hydroxylase. Contrary to previous reports, the first of these studies using normal human kidneys tissue showed that mRNA and protein for 1␣-hydroxylase is expressed throughout the nephron, with relatively strong expression in distal convoluted tubules and collecting ducts (5) . Enzyme expression appeared to be due to a single protein species with a size similar to that predicted by the amino acid sequence. Here we present immunohistochemical analyses that show for the first time the distribution of 1␣-hydroxylase protein in extrarenal tissues. Data indicate that expression of 1␣-hydroxylase is more widespread than previously thought, suggesting diverse functions for the local production of 1,25-(OH) 2 D 3 in peripheral tissues.
The discrete distribution of 1␣-hydroxylase in keratinocytes within the stratum basale of the epidermis is consistent with previous analysis of 1,25-(OH) 2 D 3 production by keratinocytes. In a series of in vitro studies Bikle and co-workers showed that vitamin D metabolism was dependent on the stage of keratinocyte development (31, 32) . Proliferating cells that are characteristic of cells within the stratum basale showed relatively high levels of 1,25-(OH) 2 D 3 synthesis that decreased as the keratinocytes differentiated toward cornified envelope precursor cells. This was accompanied by an increase in 24-hydroxylase activity and decreased VDR expression (31) . Furthermore, these changes appear to precede up-regulation of differentiation markers such as transglutaminase activity, suggesting an important autocrine or intracrine role for local 1,25-(OH) 2 D 3 production in the development of the normal epidermis. As a consequence of this, vitamin D analogs and 1,25-(OH) 2 D 3 have been used with varying degrees of success as therapy for psoriasis (33, 34) . Topical application of these agents has been shown to attenuate epidermal hyperproliferation and incomplete terminal differentiation as well as localized inflammation. It was therefore interesting to note the widespread expression of 1␣-hydroxylase throughout the dysregulated stratum spinosum in psoriatic lesions. The paradox that psoriasis is associated with unregulated local synthesis of antiproliferative 1,25-(OH) 2 D 3 may be explained by previous studies showing that dermal fibroblasts and epidermal keratinocytes from psoriatics were relatively insensitive to 1,25-(OH) 2 D 3 (35, 36) . Although other groups have failed to confirm this observation (37), the possibility remains that production of 1,25-(OH) 2 D 3 in psoriatic skin lesions is similar to that observed in macrophages from sarcoid granulomata. The localized FIG. 2 . Expression of 1␣-hydroxylase protein in normal and pathological tissue from skin and lymph nodes. A and B, Immunohistochemical analysis of normal human skin shows strong expression of 1␣-hydroxylase protein within the stratum basalis of the epidermis (arrow; magnification, ϫ150; A) and throughout the dysregulated stratum spinosum (arrow) of the epidermis in psoriatic skin (ϫ100; B). C, Negative control for 1␣-hydroxylase expression in the skin (preabsorption of primary antibody with a 100-fold excess of immunizing peptide; ϫ50). D, Expression of 1␣-hydroxylase protein in hair follicle (ϫ250). E-H, Immunolocalization of 1␣-hydroxylase in cells throughout normal human lymph node (ϫ100; E); normal tonsil, with particularly strong staining in germinal centers (arrow; ϫ200; F); lymph node granulomas (arrow; ϫ100; G), and skin affected by sarcoidosis (ϫ150; H).
FIG. 3.
Immunolocalization of 1␣-hydroxylase in colon with strong staining of the epithelium (arrow; magnification, ϫ100; A), parasympathetic ganglion of the myenteric plexus in bowel (arrow; ϫ200; B), islets of the pancreas (arrow; ϫ200; C), medulla of the adrenal gland (m; ϫ50; D), decidualized stromal cells (arrow) and trophoblasts (double arrow) in the placental bed (ϫ200; E), placental syncytiotrophoblast (arrow; ϫ200; F), Purkinje cells in the cerebellum (arrow; ϫ100; G), and neurons in the cerebral cortex (arrow; ϫ200; H).
release of inflammatory cytokines such as interferon-␥ and interleukin-2 by activated T cells is likely to provide a potent stimulus to 1␣-hydroxylase in immature keratinocytes (38) . However, although normal keratinocytes are exquisitely sensitive to exogenously added 1,25-(OH) 2 D 3 , similar feedback control may be absent in cytokine-activated keratinocytes. Thus, the question remains as to whether the unregulated expression of 1␣-hydroxylase in psoriasis and sarcoidosis is due to a common mechanism and, importantly, whether this contributes to the pathophysiology of these diseases or is a secondary consequence of the central antigenic challenge.
The dysregulation of 1␣-hydroxylase in psoriatic lesions contrasts with the apparently normal distribution of the enzyme in sarcoid epidermal tissue. In this case peripheral synthesis of 1,25-(OH) 2 D 3 appears to be due entirely to subepidermal inflammatory infiltrates, which is consistent with the macrophage-mediated responses that are associated with the granulomatous disease (15) (16) (17) (18) (19) . Expression of 1␣-hydroxylase colocalized with the cell surface antigen CD68 in both skin and lymph nodes, confirming that macrophages, rather than lymphocytes, are the most likely source of 1,25-(OH) 2 D 3 production.
Immunohistochemical detection of 1␣-hydroxylase in tissue from the placental bed confirms previous enzyme activity studies that indicated that 1,25-(OH) 2 D 3 may be produced by both decidual and trophoblastic cells (39 -43) . The functional relevance of this remains unclear, but the enzyme may contribute both to the materno-fetal transfer of calcium that is a key feature of third trimester development as well as to possible immunomodulatory actions during early stages of placentation. Although Western analyses suggested that placental 1␣-hydroxylase expression is due to the same 56-kDa protein species found in renal tissues, a smaller band was also detected that appeared to be less specific in competition with excess immunizing peptide. Further characterization of this species is required.
The presence of 1␣-hydroxylase in pancreatic islet cells provides a further link between vitamin D and insulin secretion. Recent studies in vivo and in vitro have shown that treatment with 1,25-(OH) 2 D 3 potently enhances insulin secretion in response to glucose (44, 45) . A possible role for local synthesis of 1,25-(OH) 2 D 3 as a modulator of secretory function is emphasized by the further observation that 1␣-hydroxylase is detectable in another key secretory tissue, namely the adrenal medulla. The strong presence of protein for 1␣-hydroxylase in hair follicles is interesting in view of the well documented alopecia which is associated with hereditary vitamin D-resistant rickets (46) . VDR are known to be expressed in hair follicles (47) , and abnormal expression of these receptors is thought to be the cause of the hair loss associated with hereditary vitamin D-resistant rickets. Expression of 1␣-hydroxylase was also relatively strong in sweat glands (data not shown). This together with the presence of 1␣-hydroxylase in colonic epithelial cells suggests an association between the enzyme and sites of sodium transport and regulation. A novel role for local 1,25-(OH) 2 D 3 production in salt homeostasis is also supported by our previously reported observations of 1␣-hydroxylase in the distal nephron, which is the principal site of renal sodium/water homeostasis (5).
The precise relationship between extrarenal expression of the enzyme and peripheral synthesis of 1,25-(OH) 2 D 3 remains to be determined and may be dependent on coexpression of other proteins, such as glycoprotein 330, otherwise known as megalin. Recent studies using megalin-null mice have shown that this multifunctional protein is essential for the uptake of the substrate for 1␣-hydroxylase, 25(OH)D 3 , by cells of the proximal convoluted tubule (48) . Megalin is involved in the endocytosis of 25(OH)D 3 which is bound to its carrier protein, the vitamin D-binding protein. Although this facilitates the metabolism of 25(OH)D 3 to 1,25-(OH) 2 D 3 in the kidneys, the presence of megalin at extrarenal sites suggests that regulation of substrate availability may also modulate 1␣-hydroxylase activity in peripheral tissues (49) . Key extrarenal tissues that express megalin include the parathyroid glands, mammary epithelia, and thyroid follicular cells. In addition, the defective forebrain development associated with mice lacking megalin suggests a further role in neuroepithelial cell function (50) . It was therefore interesting to note the presence of 1␣-hydroxylase protein in brain and neuronal tissues, confirming previous Northern blot analyses that indicated that mRNA for the enzyme is strongly expressed in the brain (21) .
The data presented in this study show for the first time the extrarenal distribution of 1␣-hydroxylase in human tissues. Immunohistochemical analyses confirm the discrete expression of this enzyme in immature keratinocytes and lymphoid granulomata, but also reveal novel sites for 1␣-hydroxylase expression, such as hair follicles, adrenal medulla, pancreatic islet cells, and the colon. Of particular interest are data that highlight the dysregulation of 1␣-hydroxylase in psoriatic keratinocytes. Further analysis of the expression of 1␣-hydroxylase in the skin may provide important new information on the link between vitamin D and the pathophysiology of psoriasis. 
